Biotech Startups

1 investor

Advanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers. Its work targets oncology indications such as acute myeloid leukemia, non-small cell lung cancer, and melanoma, alongside a companion diagnostic to stratify patients.

1 investor

Advanced Silicon Group works in nanotechnology, using the tagline "Nanotechnology for Life."

1 investor

AdvancedAg develops live microbial biological systems and fermentation-based technologies for agriculture and water/environmental applications, serving growers, dealers, and industry partners across North America. The company focuses on microbial consortiums and agronomic strategies aimed at improving crop performance, soil health, and reducing input dependence.

1 investor

Advanced Enzymes is a company in the enzyme/biotech industry; the page shown is an investor relations section with quarterly financial results, shareholding patterns, and corporate governance reports.

1 investor

Advantageous Systems combines nanotechnology, material science, and biotechnology to develop smart materials for medical devices, therapeutics, and clean technology applications. The company has commercialized nanotechnology solutions, particularly in water treatment.

1 investor

ADVANZ PHARMA Corp. Limited is a pharmaceutical company with a research and development pipeline of products. The page shown is a legal disclaimer gateway relating to a formal sale process under the UK City Code on Takeovers and Mergers.

1 investor

Adventris is a biotechnology company developing cancer immunotherapy treatments.

1 investor

1 investor

Advesya is a clinical-stage biotech company developing cancer and autoimmune disease therapies that target IL-1RAP, an antigen upregulated in various cancers and autoimmune conditions. A spin-out from the French Blood Institute (EFS), it is developing a CAR T-cell therapy (CCTx-001) and an antibody-drug conjugate (ADV-101).

1 investor

The site presents ADYNOVATE, a PEGylated recombinant antihemophilic Factor VIII injectable used to treat and control bleeding in adults and children with hemophilia A. It provides prescribing and safety information for patients and healthcare providers.

1 investor

Aegis operates a clinical laboratory providing definitive drug and substance testing services for healthcare providers, pharmaceutical companies, sports organizations, and corporations. The company offers medication monitoring, drug screening, and laboratory analytics integrated with electronic medical records systems.

1 investor

1 investor

Aenova is a global contract development and manufacturing organization (CDMO) serving pharmaceutical, biopharmaceutical, and healthcare companies. With 14 manufacturing sites across Europe and the U.S., the company provides end-to-end services including drug formulation, sterile and non-sterile manufacturing, packaging, and regulatory support.

1 investor

AEON Biopharma develops botulinum toxin biosimilars and therapeutic neurotoxin treatments for patients with neuromuscular disorders. The company focuses on expanding access to high-quality neurotoxin therapies through proprietary drug development.

1 investor

Aerion Bioscience develops a 6-protein biomarker panel for early detection and staging of lung cancer. The company is conducting clinical testing to validate the panel's ability to detect lung cancer, distinguish its stages and aggressiveness, and identify other lung conditions.

1 investor

A medical device company developing orthopedic and biological solutions. Leadership includes experienced physicians, financial executives, and medical technology sales professionals.

1 investor

AesculaTech develops smart materials that change properties in response to temperature and other stimuli, applying this platform to biomedical, industrial, and cosmetic products. Its first product, Humidifeye, is a smart-gel punctal plug for dry eye treatment, alongside research into patient-adaptable medical hydrogels, high-strength films, and composites.

1 investor

Aevum develops therapeutic molecules derived from exercise to treat disease. The company operates in the drug discovery and biotech field.

1 investor

1 investor

Afimmune develops new medicines for rare and inflammatory diseases through drug discovery and development programs at various clinical and pre-clinical stages.

1 investor

Afineur uses biological processes to manufacture food products sustainably, leveraging natural fermentation and biotech methods as an alternative to conventional manufacturing.

1 investor

Afton Scientific is a contract manufacturer specializing in sterile injectable production, offering aseptic processing and fill-finish services for biologics, small molecules, and emerging pharmaceutical modalities. The company serves global pharmaceutical clients requiring precision manufacturing with rigorous quality and regulatory compliance.

1 investor

Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers. The company operates a CLIA laboratory and works on molecular biology testing for reproductive health conditions.

1 investor